| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/28/2006 | WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds |
| 09/28/2006 | WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 09/28/2006 | WO2004070352A3 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 09/28/2006 | US20060217558 Method for producing 1, 3-dialkylpyridinium oligomers and related compounds using a solid support |
| 09/28/2006 | US20060217553 chemical preparation of diketopiperizine derivatives; useful as anticarcinogenic and antifungal agent |
| 09/28/2006 | US20060217432 3,6-Disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists |
| 09/28/2006 | US20060217426 Compound inhibiting in vivo phosphorous transport and medicine containing the same |
| 09/28/2006 | US20060217420 4-Ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 |
| 09/28/2006 | US20060217419 e.g. N-cis-{4-[4-(2-isopropoxy-phenyl)-piperidin-1-yl]-cyclohexyl}-3,4-dimethoxy-benzenesulfonamide; adrenoreceptor antagonist; benign prostatic hypertrophy and lower urinary tract symptoms |
| 09/28/2006 | US20060217418 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 09/28/2006 | US20060217416 Antihypoxic agents; adjust concentration of erythropoietin concentration in blood; strokes; antiepileptic agents; neurodegenerative disease ; liver disorders; antiischemic agents |
| 09/28/2006 | US20060217413 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor |
| 09/28/2006 | US20060217404 Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases |
| 09/28/2006 | US20060217399 Phenyl quinolines and their use as estrogenic agents |
| 09/28/2006 | US20060217388 Phthalazine derivatives for treating inflammatory diseases |
| 09/28/2006 | US20060217379 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 09/28/2006 | US20060217372 Diaryl ethers as opioid receptor antagonist |
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | US20060217323 Substituted indazole-O-glucosides |
| 09/28/2006 | DE10321255B4 Verfahren zur Herstellung von reinstem rac-1{4-[2- Hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2-diphenylethan-1-one fumarat und reinstes rac-1{4-[2-Hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2 A process for producing the purest rac-1 {4- [2- hydroxy-3- (5-quinolyloxy) propyl] -piperazin-1-yl} -2,2-diphenylethan-1-one fumarate and the purest rac-1 {4 - [2-hydroxy-3- (5-quinolyloxy) propyl] -piperazin-1-yl} -2,2 |
| 09/28/2006 | DE102005014628A1 New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders |
| 09/28/2006 | DE102005012873A1 Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aminocarbonyl substituted 8-N-benzimidazoles, process for their preparation and their use as medicaments |
| 09/28/2006 | CA2602583A1 Biaryl derived amide modulators of vanilloid vr1 receptor |
| 09/28/2006 | CA2602550A1 Crystalline forms of a known pyrrolidine factor xa inhibitor |
| 09/28/2006 | CA2602383A1 Substituted triazole derivatives as oxytocin antagonists |
| 09/28/2006 | CA2602241A1 Amide-substituted 8-n-benzimidazoles, method for the production thereof, and use of the same as medicaments |
| 09/28/2006 | CA2602236A1 Use of amino-substituted benzimidazoles |
| 09/28/2006 | CA2602233A1 Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments |
| 09/28/2006 | CA2602194A1 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof |
| 09/28/2006 | CA2602174A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 09/28/2006 | CA2602140A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 09/28/2006 | CA2601870A1 Conversion of 2-pyrazolines to pyrazoles using bromine |
| 09/28/2006 | CA2601424A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 09/28/2006 | CA2600757A1 Pyrrolidine derivatives as histamine h3 receptor antagonists |
| 09/28/2006 | CA2600531A1 Pyrimidine compounds and methods of use |
| 09/28/2006 | CA2600189A1 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists |
| 09/28/2006 | CA2600063A1 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 09/28/2006 | CA2599794A1 Cinnamoyl compound and use thereof |
| 09/28/2006 | CA2599390A1 Mitotic kinesin inhibitors |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1704145A1 Selective kinase inhibitors |
| 09/27/2006 | EP1703976A2 Use of metal complex compounds comprising pyridine, pyrimidine or s-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and h2o2 |
| 09/27/2006 | EP1703908A1 Aryl sulfonamide compounds and uses related thereto |
| 09/27/2006 | EP1703906A1 Immuno inhibitory pyrazolone compounds |
| 09/27/2006 | EP1703905A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
| 09/27/2006 | EP1606276B1 Preparation and use of 2-substituted-5-oxo-3- pyrazolidinecarboxylates |
| 09/27/2006 | EP1594840B1 Piperidine-benzenesulfonamide derivatives |
| 09/27/2006 | EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
| 09/27/2006 | EP1377580B1 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 09/27/2006 | EP1335906B1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 09/27/2006 | EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents |
| 09/27/2006 | EP1246622B1 Novel substituted benzimidazole dosage forms and method of using same |
| 09/27/2006 | CN1839131A Azolidinecarbonitriles and their use as DPP-IV inhibitors |
| 09/27/2006 | CN1839129A Novel n-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof |
| 09/27/2006 | CN1839128A Mitotic kinesin inhibitors |
| 09/27/2006 | CN1839127A Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
| 09/27/2006 | CN1839126A Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| 09/27/2006 | CN1839121A Hydroxamic acid compounds and methods of use thereof |
| 09/27/2006 | CN1838951A Bicycl 3.1.1]heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors |
| 09/27/2006 | CN1838890A Corrective clothes with liner |
| 09/27/2006 | CN1276754C Treatment of gastrointestinal stromal tumors |
| 09/27/2006 | CN1276753C Use of pyridine-2-yl- methylamine derivatives in the treatment of opioid dependence |
| 09/26/2006 | US7112682 intermediates for N-alkylamino indoles; amination of indoles with hydroxylamine-O-sulfonic acid using organic base, aprotic solvent to form N-amino-indoles; condensation with ketone to form hydrazone; N-(n-propyl)-N-(3-fluoro-4-pyridinyl)-1H-3-methyl-indol-1-amine; large scale; by-product inhibition |
| 09/26/2006 | US7112680 Condensing a heterocyclic ketone or aldehyde with a 2-(NH2-NH-)benzimidazole, -oxazole or -thiazole; ribonucleotide reductase inhibitors; anticarcinogenic and -tumor agents; also useful against multidrug resistant cells |
| 09/26/2006 | US7112678 Regiospecific synthesis of nicotine derivatives |
| 09/26/2006 | US7112603 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/26/2006 | US7112600 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity |
| 09/26/2006 | US7112596 Prenylation inhibitors and methods of their synthesis and use |
| 09/26/2006 | US7112595 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 09/26/2006 | US7112593 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient |
| 09/26/2006 | US7112589 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
| 09/26/2006 | US7112587 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 09/26/2006 | US7112585 For therapy of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms |
| 09/26/2006 | US7112583 Containing a benzodiazepine ring, e.g., (2(R)-Cyclopentylmethyl-3(S)-hydroxyl-1-oxo-5-phenylpentyl)amino-1-methyl-5-(4-fluoro-phenyl)-2,3-dihydro-1H-1,5-benzodiazepin-2-one; treating Alzheimer's disease and Down's Syndrome |
| 09/26/2006 | US7112579 26,27-Homologated-20-EPI-2-alkyl-19-nor-vitamin D compounds |
| 09/26/2006 | US7112553 Particularly isothiazolylamino- or pyridinylamino- substituted; e.g., N-[2-ethoxymethyl-4-chloro-3-methylisothiazolin-5-ylidene]-[2-(2-methylpropyl)indazol-5-yl)acetamide and N-(4-chloro-3-methylisothiazol-5-yl)-N-(ethoxymethyl)-(2-propylbenzotriazol-5-yl)acetamide |
| 09/26/2006 | CA2278694C Sulfamide-metalloprotease inhibitors |
| 09/21/2006 | WO2006099605A2 Dimeric and trimeric nucleic acid dyes, and associated systems and methods |
| 09/21/2006 | WO2006099379A2 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
| 09/21/2006 | WO2006099231A1 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 09/21/2006 | WO2006099091A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006099060A2 Process for the preparation of opioid modulators |
| 09/21/2006 | WO2006099032A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006099031A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006098982A1 Process for the preparation of opioid modulators |
| 09/21/2006 | WO2006098684A1 Novel compounds ii 2-pyridine derivatives as inhibitors of neutrophile elastase. |
| 09/21/2006 | WO2006098683A1 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 09/21/2006 | WO2006098505A1 Platinum complex compound and organic electroluminescent device |
| 09/21/2006 | WO2006097848A1 Hiv-1 virion maturation inhibitors, compositions and treatments using the same |
| 09/21/2006 | WO2006097808A1 Benzimidazolone derivatives as cb2 receptor ligands |
| 09/21/2006 | WO2006097766A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists |
| 09/21/2006 | WO2006097624A1 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof |
| 09/21/2006 | WO2006097534A1 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication |
| 09/21/2006 | WO2006097474A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 09/21/2006 | WO2006097460A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 09/21/2006 | WO2006097441A1 Potassium channel modulating agents and their medical use |
| 09/21/2006 | WO2006097261A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 09/21/2006 | WO2006097175A1 Dpp-iv inhibitors |
| 09/21/2006 | WO2006097130A1 Compounds absorbing uv light and blue light, as a medium for optical data storage |
| 09/21/2006 | WO2006079556A3 Substituted 5-phenyl pyrimidines i in therapy |